Display options
Cite
Sulkes A, Ruchlemer R, Neria SB, et al. Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias?. Leuk Lymphoma. 1991;4(5):405-9doi: 10.3109/10428199109068093.
Sulkes, A., Ruchlemer, R., Neria, S. B., Leizerowitz, R., Abeliovich, D., & Polliack, A. (1991). Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias?. Leukemia & lymphoma, 4(5), 405-9. https://doi.org/10.3109/10428199109068093
Sulkes, A, et al. "Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias?." Leukemia & lymphoma vol. 4,5 (1991): 405-9. doi: https://doi.org/10.3109/10428199109068093
Sulkes A, Ruchlemer R, Neria SB, Leizerowitz R, Abeliovich D, Polliack A. Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias?. Leuk Lymphoma. 1991;4(5):405-9. doi: 10.3109/10428199109068093. PMID: 27467675.
Copy Download .nbib Format: NLM
Share it on

Leuk Lymphoma. 1991;4(5):405-9. doi: 10.3109/10428199109068093.

Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias?.

Leukemia & lymphoma

A Sulkes, R Ruchlemer, S B Neria, R Leizerowitz, D Abeliovich, A Polliack

Affiliations

  1. a Sharett Institute of Oncology, Lymphoma-Leukemia Unit, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
  2. b Department of Hematology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
  3. c Department of Human Genetics, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

PMID: 27467675 DOI: 10.3109/10428199109068093

Abstract

We describe the clinical course of a 61 years old patient who developed fulminant acute monoblastic leukemia (MSA, FAB) while still on systemic chemotherapy for an advanced adenocarcinoma of the ovary. The leukemia developed following chemotherapy with Cyclophosphamide and Cisplatin (9 cycles), and then Cyclophosphamide and Carboplatin (6 cycles) resulting in a partial remission of the ovarian tumor. Survival from the onset of acute leukemia was extremely short and the cause of death was intracerebral bleeding. Cytogenetic analysis of the leukemic cells revealed a 9:11 translocation, a pattern usually occurring in de novo leukemias. The literature on the association of solid tumors, particularly ovarian cancer, with acute leukemia is reviewed; while systemic chemotherapy for ovarian cancer definitely increases the risk of secondary leukemia, especially if alkylating agents are administered, the occurrence of leukemia during the administration of chemotherapy for the solid tumor is distinctly unusual. Our patient seems to be an additional example of a recently described therapy-related variant of acute leukemia developing shortly after the onset of chemotherapy and characterized by a rapidly downhill clinical course, a monocytic lineage and a cytogenetic rearrangement t(9;11)(p22;q23). While the number of these newly described cases is still small, this additional example should increase the awareness of this potential association in Cisplatin-treated patients.

Keywords: Acute leukemia; chemotherapy; monoblastic leukemia; ovarian cancer; secondary leukemia; t(9:11)

Publication Types